Connect your AI

Simulations Plus SLP Interest receivable on interest rate and cross currency swaps

Interest receivable on interest rate and cross currency swaps at other companies

Bio-Rad LaboratoriesBIO

——

Other financials

Income statement

Revenue$24.3M+8.3%

Gross profit$16.1M+23.0%

Operating income$5.6M+108%

Net income$4.5M+47.5%

EPS (diluted)$0.22+46.7%

Balance sheet

Cash & equivalents$25.7M+134%

Total debt$508.0K-36.2%

Total equity$133.8M-29.4%

Total assets$146.5M-27.3%

Cash flow

Operating cash flow$6.4M+13.1%

CapEx$46.0K-30.3%

Free cash flow$6.4M+13.6%

Valuation

Market cap$366.73M+5.2%

Enterprise value$341.51M+6.0%

P/S4.6×+0.2×

Profitability

Gross margin62%+6.7pp

Operating margin-84.3%—

Net margin-78%-87.2pp

FCF margin29.5%+14.9pp

Returns & leverage

Return on equity-38.8%-42.8pp

Debt / equity0×0.0×

Current ratio5.5×+1.1×

Where this comes from

Reported directly by Simulations Plus in its filing.

Tagged under the XBRL concept us-gaap:InterestReceivableCurrent.

The official record: Simulations Plus’s 10-Q, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Simulations Plus's interest receivable on interest rate and cross currency swaps.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Simulations Plus's interest receivable on interest rate and cross currency swaps?: Simulations Plus (SLP) reported interest receivable on interest rate and cross currency swaps of $100K in Q4 2025.